Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Endo International plcENDP · Entity 124463 | Director · President, CEO | March 29, 2022 | March 31, 2022 |
| Ocugen, Inc.OCGN · Entity 5550 | Director | June 11, 2026 | June 15, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Endo International plc
Report date March 29, 2022 · Filed March 31, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary SharesSEC Table I · non-derivative | Direct | 422,066 |
Ending reported balance
After 2022-03-30 transaction · row 4
3 source rows · reconciled sequenceRow 1 · 2022-03-29 · Tax withholding · Disposed 8,437 · Balance 396,293 F1: Thirty-three and one-third percent (33 1/3%) of Mr. Coleman's March 29, 2019 grant of restricted stock units (RSUs) vested on March 29, 2022. F2: These shares represent stock withheld by Endo International plc to satisfy Mr. Coleman's tax withholding obligations on shares acquired upon vesting of RSUs. F3: Represents the vesting price which is the average of the high and low share price on March 29, 2022. Row 3 · 2022-03-30 · Exercise / conversion · Acquired 35,910 · Balance 432,203 F4: On March 30, 2022, based on performance against target levels with respect to Mr. Coleman's March 29, 2019 grant of performance share units, these awards were released and the performance share units were converted into 35,910 ordinary shares. Of this amount, 10,137 ordinary shares were withheld by Endo International plc to satisfy Mr. Coleman's tax withholding obligations on shares acquired upon vesting, with the remainder transferred to Mr. Coleman. F7: This represents the automatic conversion of performance share units granted to Mr. Coleman on March 29, 2019 to ordinary shares of Endo International plc pursuant to the terms of the underlying award agreement. Row 4 · 2022-03-30 · Tax withholding · Disposed 10,137 · Balance 422,066 F4: On March 30, 2022, based on performance against target levels with respect to Mr. Coleman's March 29, 2019 grant of performance share units, these awards were released and the performance share units were converted into 35,910 ordinary shares. Of this amount, 10,137 ordinary shares were withheld by Endo International plc to satisfy Mr. Coleman's tax withholding obligations on shares acquired upon vesting, with the remainder transferred to Mr. Coleman. F8: These shares represent stock withheld by Endo International plc to satisfy Mr. Coleman's tax withholding obligations on shares acquired upon vesting of performance share units. F3: Represents the vesting price which is the average of the high and low share price on March 29, 2022. |
| Stock Incentive Plan Performance Share UnitsSEC Table I · non-derivative | Direct | 1,342,584 |
Reported balance
After 2022-03-30 transaction · row 2
1 source rowRow 2 · 2022-03-30 · Exercise / conversion · Disposed 89,663 · Balance 1,342,584 F4: On March 30, 2022, based on performance against target levels with respect to Mr. Coleman's March 29, 2019 grant of performance share units, these awards were released and the performance share units were converted into 35,910 ordinary shares. Of this amount, 10,137 ordinary shares were withheld by Endo International plc to satisfy Mr. Coleman's tax withholding obligations on shares acquired upon vesting, with the remainder transferred to Mr. Coleman. F5: Represents the target number of shares issuable upon Endo International plc's achievement of both: (a) shareholder return performance metrics over a cumulative three-year period and (b) free cash flow performance metrics over a cumulative three-year period, each as determined by Endo International plc's Board of Directors at the end of such periods. F6: These securities were granted to Mr. Coleman in consideration of his services as a senior executive of Endo International plc. |
Filing footnotes · ownership attribution and instrument terms
F1: Thirty-three and one-third percent (33 1/3%) of Mr. Coleman's March 29, 2019 grant of restricted stock units (RSUs) vested on March 29, 2022.
F2: These shares represent stock withheld by Endo International plc to satisfy Mr. Coleman's tax withholding obligations on shares acquired upon vesting of RSUs.
F3: Represents the vesting price which is the average of the high and low share price on March 29, 2022.
F4: On March 30, 2022, based on performance against target levels with respect to Mr. Coleman's March 29, 2019 grant of performance share units, these awards were released and the performance share units were converted into 35,910 ordinary shares. Of this amount, 10,137 ordinary shares were withheld by Endo International plc to satisfy Mr. Coleman's tax withholding obligations on shares acquired upon vesting, with the remainder transferred to Mr. Coleman.
F5: Represents the target number of shares issuable upon Endo International plc's achievement of both: (a) shareholder return performance metrics over a cumulative three-year period and (b) free cash flow performance metrics over a cumulative three-year period, each as determined by Endo International plc's Board of Directors at the end of such periods.
F6: These securities were granted to Mr. Coleman in consideration of his services as a senior executive of Endo International plc.
F7: This represents the automatic conversion of performance share units granted to Mr. Coleman on March 29, 2019 to ordinary shares of Endo International plc pursuant to the terms of the underlying award agreement.
F8: These shares represent stock withheld by Endo International plc to satisfy Mr. Coleman's tax withholding obligations on shares acquired upon vesting of performance share units.
Ocugen, Inc.
Report date June 11, 2026 · Filed June 15, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.22 · Expires 2036-06-11 | Direct | 170,100 |
Reported balance
After 2026-06-11 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-06-11 · Grant · Acquired 170,100 · Balance 170,100 F1: The option vests upon the earlier of (a) June 11, 2027 or (b) Ocugen, Inc.'s next annual meeting of stockholders, subject to the Reporting Person's continued service through the applicable vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: The option vests upon the earlier of (a) June 11, 2027 or (b) Ocugen, Inc.'s next annual meeting of stockholders, subject to the Reporting Person's continued service through the applicable vesting date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 11, 2026 Filed Jun 15, 2026 20:30 UTC | Ocugen, Inc. OCGN · Entity 5550 | GrantStock Option (Right to Buy) · Derivative | 170,100 | $0.00 Strike: $1.22 | $0.00 |
DisclosureSEC source: 0001104659-26-074064 · tm2617964-1_4seq1.xml · derivative · entry 1 Coleman Blaise · CIK 0001689280 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 170,100 Underlying: Common Stock · 170,100 shares Expires 2036-06-11 F1 · derivative.exercise_date: The option vests upon the earlier of (a) June 11, 2027 or (b) Ocugen, Inc.'s next annual meeting of stockholders, subject to the Reporting Person's continued service through the applicable vesting date. Read SEC document |
| June 05, 2025 Filed Jun 9, 2025 21:19 UTC | Ocugen, Inc. OCGN · Entity 5550 | GrantOption (Right to Buy) · Derivative | 151,316 | $0.00 Strike: $0.95 | $0.00 |
DisclosureSEC source: 0001062993-25-011274 · form4.xml · derivative · entry 1 Coleman Blaise · CIK 0001689280 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 151,316 Underlying: Common Stock · 151,316 shares Expires 2035-06-05 F1 · derivative.exercise_date: The option vests monthly in equal installments over three years commencing on July 5, 2025, subject to the Reporting Person's continued service through the applicable vesting date. Read SEC document |
| March 30, 2022 Filed Mar 31, 2022 20:02 UTC | Endo International plc ENDP · Entity 124463 | Tax withholdingOrdinary Shares | 10,137 | $2.52 | $25,545.24 |
DisclosureSEC source: 0001593034-22-000028 · wf-form4_164875691737822.xml · nonDerivative · entry 4 Coleman Blaise · CIK 0001689280 · Director · President, CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 422,066 F4 · date: On March 30, 2022, based on performance against target levels with respect to Mr. Coleman's March 29, 2019 grant of performance share units, these awards were released and the performance share units were converted into 35,910 ordinary shares. Of this amount, 10,137 ordinary shares were withheld by Endo International plc to satisfy Mr. Coleman's tax withholding obligations on shares acquired upon vesting, with the remainder transferred to Mr. Coleman. F8 · shares: These shares represent stock withheld by Endo International plc to satisfy Mr. Coleman's tax withholding obligations on shares acquired upon vesting of performance share units. F3 · price: Represents the vesting price which is the average of the high and low share price on March 29, 2022. Read SEC document |
| March 30, 2022 Filed Mar 31, 2022 20:02 UTC | Endo International plc ENDP · Entity 124463 | Exercise / conversionOrdinary Shares | 35,910 | $0.00 | $0.00 |
DisclosureSEC source: 0001593034-22-000028 · wf-form4_164875691737822.xml · nonDerivative · entry 3 Coleman Blaise · CIK 0001689280 · Director · President, CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 432,203 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · date: On March 30, 2022, based on performance against target levels with respect to Mr. Coleman's March 29, 2019 grant of performance share units, these awards were released and the performance share units were converted into 35,910 ordinary shares. Of this amount, 10,137 ordinary shares were withheld by Endo International plc to satisfy Mr. Coleman's tax withholding obligations on shares acquired upon vesting, with the remainder transferred to Mr. Coleman. F7 · price: This represents the automatic conversion of performance share units granted to Mr. Coleman on March 29, 2019 to ordinary shares of Endo International plc pursuant to the terms of the underlying award agreement. Read SEC document |
| March 30, 2022 Filed Mar 31, 2022 20:02 UTC | Endo International plc ENDP · Entity 124463 | Exercise / conversionStock Incentive Plan Performance Share Units | 89,663 | $0.00 | $0.00 |
DisclosureSEC source: 0001593034-22-000028 · wf-form4_164875691737822.xml · nonDerivative · entry 2 Coleman Blaise · CIK 0001689280 · Director · President, CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,342,584 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · date: On March 30, 2022, based on performance against target levels with respect to Mr. Coleman's March 29, 2019 grant of performance share units, these awards were released and the performance share units were converted into 35,910 ordinary shares. Of this amount, 10,137 ordinary shares were withheld by Endo International plc to satisfy Mr. Coleman's tax withholding obligations on shares acquired upon vesting, with the remainder transferred to Mr. Coleman. F5 · shares: Represents the target number of shares issuable upon Endo International plc's achievement of both: (a) shareholder return performance metrics over a cumulative three-year period and (b) free cash flow performance metrics over a cumulative three-year period, each as determined by Endo International plc's Board of Directors at the end of such periods. F6 · price: These securities were granted to Mr. Coleman in consideration of his services as a senior executive of Endo International plc. Read SEC document |
| March 29, 2022 Filed Mar 31, 2022 20:02 UTC | Endo International plc ENDP · Entity 124463 | Tax withholdingOrdinary Shares | 8,437 | $2.52 | $21,261.24 |
DisclosureSEC source: 0001593034-22-000028 · wf-form4_164875691737822.xml · nonDerivative · entry 1 Coleman Blaise · CIK 0001689280 · Director · President, CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 396,293 F1 · date: Thirty-three and one-third percent (33 1/3%) of Mr. Coleman's March 29, 2019 grant of restricted stock units (RSUs) vested on March 29, 2022. F2 · shares: These shares represent stock withheld by Endo International plc to satisfy Mr. Coleman's tax withholding obligations on shares acquired upon vesting of RSUs. F3 · price: Represents the vesting price which is the average of the high and low share price on March 29, 2022. Read SEC document |
| March 05, 2022 Filed Mar 8, 2022 21:03 UTC | Endo International plc ENDP · Entity 124463 | Tax withholdingOrdinary Shares | 31,886 | $2.34 | $74,692.96 |
DisclosureSEC source: 0001593034-22-000019 · wf-form4_164677337286177.xml · nonDerivative · entry 1 Coleman Blaise · CIK 0001689280 · Director · President, CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 374,843 F1 · date: Thirty-three and one-third percent (33 1/3%) of Mr. Coleman's March 5, 2021 grant of restricted stock units (RSUs) vested on March 5, 2022. F2 · shares: These shares represent stock withheld by Endo International plc to satisfy Mr. Coleman's tax withholding obligations on shares acquired upon vesting of RSUs. F3 · price: Represents the vesting price which is the average of the high and low share price on March 4, 2022, the last trading day prior to vesting. Read SEC document |
| April 06, 2021 Filed Apr 6, 2021 20:52 UTC | Endo International plc ENDP · Entity 124463 | Tax withholdingOrdinary Shares | 28,955 | $7.37 | $213,398.35 |
DisclosureSEC source: 0001593034-21-000051 · wf-form4_161774225189552.xml · nonDerivative · entry 4 Coleman Blaise · CIK 0001689280 · Director · President, CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 293,472 F4 · date: On April 6, 2021, based on performance against target levels with respect to Mr. Coleman's April 2, 2018 grant of performance share units, these awards were released and the performance share units were converted into 66,985 ordinary shares. Of this amount, 28,955 ordinary shares were withheld by Endo International plc to satisfy Mr. Coleman's tax withholding obligations on shares acquired upon vesting, with the remainder transferred to Mr. Coleman. F8 · shares: These shares represent stock withheld by Endo International plc to satisfy Mr. Coleman's tax withholding obligations on shares acquired upon vesting of performance share units. F3 · price: Represents the vesting price which is the average of the high and low share price on April 1, 2021, the last trading day prior to vesting. Read SEC document |
| April 06, 2021 Filed Apr 6, 2021 20:52 UTC | Endo International plc ENDP · Entity 124463 | Exercise / conversionOrdinary Shares | 66,985 | $0.00 | $0.00 |
DisclosureSEC source: 0001593034-21-000051 · wf-form4_161774225189552.xml · nonDerivative · entry 3 Coleman Blaise · CIK 0001689280 · Director · President, CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 322,427 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · date: On April 6, 2021, based on performance against target levels with respect to Mr. Coleman's April 2, 2018 grant of performance share units, these awards were released and the performance share units were converted into 66,985 ordinary shares. Of this amount, 28,955 ordinary shares were withheld by Endo International plc to satisfy Mr. Coleman's tax withholding obligations on shares acquired upon vesting, with the remainder transferred to Mr. Coleman. F7 · price: This represents the automatic conversion of performance share units granted to Mr. Coleman on April 2, 2018 to ordinary shares of Endo International plc pursuant to the terms of the underlying award agreement. Read SEC document |
| April 06, 2021 Filed Apr 6, 2021 20:52 UTC | Endo International plc ENDP · Entity 124463 | Exercise / conversionStock Incentive Plan Performance Share Units | 54,563 | $0.00 | $0.00 |
DisclosureSEC source: 0001593034-21-000051 · wf-form4_161774225189552.xml · nonDerivative · entry 2 Coleman Blaise · CIK 0001689280 · Director · President, CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,432,247 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · date: On April 6, 2021, based on performance against target levels with respect to Mr. Coleman's April 2, 2018 grant of performance share units, these awards were released and the performance share units were converted into 66,985 ordinary shares. Of this amount, 28,955 ordinary shares were withheld by Endo International plc to satisfy Mr. Coleman's tax withholding obligations on shares acquired upon vesting, with the remainder transferred to Mr. Coleman. F5 · shares: Represents the target number of shares issuable upon Endo International plc's achievement of both: (a) shareholder return performance metrics over a cumulative three-year period and (b) free cash flow performance metrics over three successive one-year periods, each as determined by Endo International plc's Board of Directors at the end of such periods. F6 · price: These securities were granted to Mr. Coleman in consideration of his services as a senior executive of Endo International plc. Read SEC document |
| April 02, 2021 Filed Apr 6, 2021 20:52 UTC | Endo International plc ENDP · Entity 124463 | Tax withholdingOrdinary Shares | 23,587 | $7.37 | $173,836.19 |
DisclosureSEC source: 0001593034-21-000051 · wf-form4_161774225189552.xml · nonDerivative · entry 1 Coleman Blaise · CIK 0001689280 · Director · President, CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 255,442 F1 · date: Thirty-three and one-third percent (33 1/3%) of Mr. Coleman's April 2, 2018 grant of restricted stock units (RSUs) vested on April 2, 2021. F2 · shares: These shares represent stock withheld by Endo International plc to satisfy Mr. Coleman's tax withholding obligations on shares acquired upon vesting of RSUs. F3 · price: Represents the vesting price which is the average of the high and low share price on April 1, 2021, the last trading day prior to vesting. Read SEC document |
| March 29, 2021 Filed Mar 31, 2021 20:02 UTC | Endo International plc ENDP · Entity 124463 | Tax withholdingOrdinary Shares | 12,920 | $7.31 | $94,482.67 |
DisclosureSEC source: 0001593034-21-000037 · wf-form4_161722090479842.xml · nonDerivative · entry 1 Coleman Blaise · CIK 0001689280 · Director · President, CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 224,466 F1 · date: Thirty-three and one-third percent (33 1/3%) of Mr. Coleman's March 29, 2019 grant of restricted stock units (RSUs) vested on March 29, 2021. F2 · shares: These shares represent stock withheld by Endo International plc to satisfy Mr. Coleman's tax withholding obligations on shares acquired upon vesting of RSUs. F3 · price: Represents the vesting price which is the average of the high and low share price on March 29, 2021. Read SEC document |
| March 05, 2021 Filed Mar 9, 2021 21:53 UTC | Endo International plc ENDP · Entity 124463 | Grant2015 Stock Incentive Plan Restricted Stock Units (RSU) | 339,771 | $0.00 | $0.00 |
DisclosureSEC source: 0001593034-21-000025 · wf-form4_161532680144564.xml · nonDerivative · entry 1 Coleman Blaise · CIK 0001689280 · Director · President, CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 454,109 F1 · security: Upon each vesting date, each vested restricted stock unit (RSU) automatically converts into one (1) ordinary share of Endo International plc. One-third (1/3) of these RSUs generally vest, and thus expire, on each of March 5, 2022, March 5, 2023 and March 5, 2024. F2 · price: These RSUs were granted to Mr. Coleman in consideration of his services as President and Chief Executive Officer of Endo International plc. Read SEC document |
| August 10, 2020 Filed Aug 12, 2020 20:14 UTC | Endo International plc ENDP · Entity 124463 | Tax withholdingOrdinary Shares | 16,511 | $3.40 | $56,137.40 |
DisclosureSEC source: 0001593034-20-000076 · wf-form4_159726326861977.xml · nonDerivative · entry 1 Coleman Blaise · CIK 0001689280 · Director · President, CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 207,498 F1 · date: Thirty-three and one-third percent (33 1/3%) of Mr. Coleman's August 10, 2017 grant of restricted stock units (RSUs) vested on August 10, 2020. F2 · shares: These shares represent stock withheld by Endo International plc to satisfy Mr. Coleman's tax withholding obligations on shares acquired upon vesting of RSUs. F3 · price: Represents the vesting price which is the average of the high and low share price on August 10, 2020. Read SEC document |
| April 02, 2020 Filed Apr 6, 2020 20:11 UTC | Endo International plc ENDP · Entity 124463 | Tax withholdingOrdinary Shares | 25,056 | $3.16 | $79,176.96 |
DisclosureSEC source: 0001593034-20-000039 · wf-form4_158620388087989.xml · nonDerivative · entry 1 Coleman Blaise · CIK 0001689280 · Director · President, CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 185,815 F1 · date: Thirty-three and one-third percent (33 1/3%) of Mr. Coleman's April 2, 2018 grant of restricted stock units (RSUs) vested on April 2, 2020. F2 · shares: These shares represent stock withheld by Endo International plc to satisfy Mr. Coleman's tax withholding obligations on shares acquired upon vesting of RSUs. F3 · price: Represents the vesting price which is the average of the high and low share price on April 2, 2020. Read SEC document |
| March 29, 2020 Filed Mar 31, 2020 20:24 UTC | Endo International plc ENDP · Entity 124463 | Tax withholdingOrdinary Shares | 13,725 | $3.52 | $48,312.00 |
DisclosureSEC source: 0001593034-20-000033 · wf-form4_158568623530486.xml · nonDerivative · entry 1 Coleman Blaise · CIK 0001689280 · Director · President, CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 156,308 F1 · date: Thirty-three and one-third percent (33 1/3%) of Mr. Coleman's March 29, 2019 grant of restricted stock units (RSUs) vested on March 29, 2020. F2 · shares: These shares represent stock withheld by Endo International plc to satisfy Mr. Coleman's tax withholding obligations on shares acquired upon vesting of RSUs. F3 · price: Represents the vesting price which is the average of the high and low share price on March 27, 2020, the last trading day prior to vesting. Read SEC document |
| February 25, 2020 Filed Feb 25, 2020 21:44 UTC | Endo International plc ENDP · Entity 124463 | Tax withholdingOrdinary Shares | 8,579 | $6.19 | $53,104.01 |
DisclosureSEC source: 0001593034-20-000014 · wf-form4_158266703869234.xml · nonDerivative · entry 5 Coleman Blaise · CIK 0001689280 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 140,145 F6 · date: On February 25, 2020, based on performance against target levels with respect to Mr. Coleman's February 21, 2017 grant of performance share units, these awards were released and the performance share units were converted into 30,395 ordinary shares. Of this amount, 8,579 ordinary shares were withheld by Endo International plc to satisfy Mr. Coleman's tax withholding obligations on shares acquired upon vesting, with the remainder transferred to Mr. Coleman. F10 · shares: These shares represent stock withheld by Endo International plc to satisfy Mr. Coleman's tax withholding obligations on shares acquired upon vesting of performance share units. F3 · price: Represents the vesting price which is the average of the high and low share price on February 21, 2020. Read SEC document |
| February 25, 2020 Filed Feb 25, 2020 21:44 UTC | Endo International plc ENDP · Entity 124463 | Exercise / conversionOrdinary Shares | 30,395 | $0.00 | $0.00 |
DisclosureSEC source: 0001593034-20-000014 · wf-form4_158266703869234.xml · nonDerivative · entry 4 Coleman Blaise · CIK 0001689280 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 148,724 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · date: On February 25, 2020, based on performance against target levels with respect to Mr. Coleman's February 21, 2017 grant of performance share units, these awards were released and the performance share units were converted into 30,395 ordinary shares. Of this amount, 8,579 ordinary shares were withheld by Endo International plc to satisfy Mr. Coleman's tax withholding obligations on shares acquired upon vesting, with the remainder transferred to Mr. Coleman. F9 · price: This represents the automatic conversion of performance share units granted to Mr. Coleman on February 21, 2017 to ordinary shares of Endo International plc pursuant to the terms of the underlying award agreement. Read SEC document |
| February 25, 2020 Filed Feb 25, 2020 21:44 UTC | Endo International plc ENDP · Entity 124463 | Exercise / conversionStock Incentive Plan Performance Share Units | 33,169 | $0.00 | $0.00 |
DisclosureSEC source: 0001593034-20-000014 · wf-form4_158266703869234.xml · nonDerivative · entry 3 Coleman Blaise · CIK 0001689280 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 144,226 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · date: On February 25, 2020, based on performance against target levels with respect to Mr. Coleman's February 21, 2017 grant of performance share units, these awards were released and the performance share units were converted into 30,395 ordinary shares. Of this amount, 8,579 ordinary shares were withheld by Endo International plc to satisfy Mr. Coleman's tax withholding obligations on shares acquired upon vesting, with the remainder transferred to Mr. Coleman. F7 · shares: Represents the target number of shares issuable upon Endo International plc's achievement of both: (a) shareholder return performance metrics over a cumulative three-year period and (b) free cash flow performance metrics over three successive one-year periods, each as determined by Endo International plc's Board of Directors at the end of such periods. F8 · price: These securities were granted to Mr. Coleman in consideration of his services as the Executive Vice President and Chief Financial Officer of Endo International plc. Read SEC document |
| February 23, 2020 Filed Feb 25, 2020 21:44 UTC | Endo International plc ENDP · Entity 124463 | Tax withholdingOrdinary Shares | 105 | $6.19 | $649.95 |
DisclosureSEC source: 0001593034-20-000014 · wf-form4_158266703869234.xml · nonDerivative · entry 2 Coleman Blaise · CIK 0001689280 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 118,329 F4 · date: Twenty-five percent (25%) of Mr. Coleman's February 23, 2016 grant of RSUs vested on February 23, 2020. F2 · shares: These shares represent stock withheld by Endo International plc to satisfy Mr. Coleman's tax withholding obligations on shares acquired upon vesting of RSUs. F5 · price: Represents the vesting price which is the average of the high and low share price on February 21, 2020, the last trading day prior to vesting. Read SEC document |
| February 21, 2020 Filed Feb 25, 2020 21:44 UTC | Endo International plc ENDP · Entity 124463 | Tax withholdingOrdinary Shares | 3,121 | $6.19 | $19,318.99 |
DisclosureSEC source: 0001593034-20-000014 · wf-form4_158266703869234.xml · nonDerivative · entry 1 Coleman Blaise · CIK 0001689280 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 118,059 F1 · date: Thirty-three and one-third percent (33 1/3%) of Mr. Coleman's February 21, 2017 grant of restricted stock units (RSUs) vested on February 21, 2020. F2 · shares: These shares represent stock withheld by Endo International plc to satisfy Mr. Coleman's tax withholding obligations on shares acquired upon vesting of RSUs. F3 · price: Represents the vesting price which is the average of the high and low share price on February 21, 2020. Read SEC document |
| August 10, 2019 Filed Aug 13, 2019 21:51 UTC | Endo International plc ENDP · Entity 124463 | Tax withholdingOrdinary Shares | 16,511 | $2.49 | $41,112.39 |
DisclosureSEC source: 0001593034-19-000034 · wf-form4_156573306710927.xml · nonDerivative · entry 1 Coleman Blaise · CIK 0001689280 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,124 F1 · date: Thirty-three and one-third percent (33 1/3%) of Mr. Coleman's August 10, 2017 grant of restricted stock units (RSUs) vested on August 10, 2019. F2 · shares: These shares represent stock withheld by Endo International plc to satisfy Mr. Coleman's tax withholding obligations on shares acquired upon vesting of RSUs. F3 · price: Represents the vesting price which is the average of the high and low share price on August 9, 2019, the last trading day prior to vesting. Read SEC document |
| May 16, 2019 Filed May 20, 2019 20:04 UTC | Endo International plc ENDP · Entity 124463 | Tax withholdingOrdinary Shares | 1,158 | $6.69 | $7,747.02 |
DisclosureSEC source: 0001209191-19-031324 · doc4.xml · nonDerivative · entry 1 Coleman Blaise · CIK 0001689280 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,441 F1 · date: Thirty-three and one-third percent (33 1/3%) of Mr. Coleman's May 16, 2016 grant of restricted stock units (RSUs) vested on May 16, 2019. F2 · shares: These shares represent stock withheld by Endo International plc to satisfy Mr. Coleman's tax withholding obligations on shares acquired upon vesting of RSUs. F3 · price: Represents the vesting price which is the average of the high and low share price on May 16, 2019. Read SEC document |
| April 02, 2019 Filed Apr 4, 2019 20:32 UTC | Endo International plc ENDP · Entity 124463 | Tax withholdingOrdinary Shares | 23,674 | $8.10 | $191,759.40 |
DisclosureSEC source: 0001209191-19-023653 · doc4.xml · nonDerivative · entry 1 Coleman Blaise · CIK 0001689280 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,919 F1 · date: Thirty-three and one-third percent (33 1/3%) of Mr. Coleman's April 2, 2018 grant of restricted stock units (RSUs) vested on April 2, 2019. F2 · shares: These shares represent stock withheld by Endo International plc to satisfy Mr. Coleman's tax withholding obligations on shares acquired upon vesting of RSUs. F3 · price: Represents the vesting price which is the average of the high and low share price on April 2, 2019. Read SEC document |
| March 29, 2019 Filed Apr 2, 2019 20:07 UTC | Endo International plc ENDP · Entity 124463 | Grant2015 Stock Incentive Plan Restricted Stock Units (RSU) | 89,663 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-19-022358 · doc4.xml · nonDerivative · entry 1 Coleman Blaise · CIK 0001689280 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 343,852 F1 · security: Upon each vesting date, each vested restricted stock unit automatically converts into one (1) ordinary share of Endo International plc. One-third (1/3) of these restricted stock units (RSUs) generally vest, thus expire, on each of March 29, 2020, March 29, 2021 and March 29, 2022. F2 · price: These RSUs were granted to Mr. Coleman in consideration of his services as Executive Vice President and Chief Financial Officer of Endo International plc. Read SEC document |
| February 23, 2019 Filed Feb 26, 2019 22:33 UTC | Endo International plc ENDP · Entity 124463 | Tax withholdingOrdinary Shares | 105 | $10.51 | $1,103.55 |
DisclosureSEC source: 0001209191-19-013654 · doc4.xml · nonDerivative · entry 1 Coleman Blaise · CIK 0001689280 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,029 F1 · date: Twenty-five percent (25%) of Mr. Coleman's February 23, 2016 grant of restricted stock units (RSUs) vested on February 23, 2019. F2 · shares: These shares represent stock withheld by Endo International plc to satisfy Mr. Coleman's tax withholding obligations on shares acquired upon vesting of RSUs. F3 · price: Represents the vesting price which is the average of the high and low share price on February 22, 2019, the last trading day prior to vesting. Read SEC document |
| February 21, 2019 Filed Feb 25, 2019 21:42 UTC | Endo International plc ENDP · Entity 124463 | Tax withholdingOrdinary Shares | 3,252 | $10.38 | $33,755.76 |
DisclosureSEC source: 0001209191-19-013001 · doc4.xml · nonDerivative · entry 1 Coleman Blaise · CIK 0001689280 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,759 F1 · date: Thirty-three and one-third percent (33 1/3%) of Mr. Coleman's February 21, 2017 grant of restricted stock units (RSUs) vested on February 21, 2019. F2 · shares: These shares represent stock withheld by Endo International plc to satisfy Mr. Coleman's tax withholding obligations on shares acquired upon vesting of RSUs. F3 · price: Represents the vesting price which is the average of the high and low share price on February 21, 2019. Read SEC document |
| August 10, 2018 Filed Aug 14, 2018 20:08 UTC | Endo International plc ENDP · Entity 124463 | Tax withholdingOrdinary Shares | 13,636 | $15.82 | $215,721.52 |
DisclosureSEC source: 0001209191-18-046591 · doc4.xml · nonDerivative · entry 1 Coleman Blaise · CIK 0001689280 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,955 F1 · date: Thirty-three and a third percent (33 1/3%) of Mr. Coleman's August 10, 2017 grant of restricted stock units (RSUs) vested on August 10, 2018. F2 · shares: These shares represent stock withheld by Endo International plc to satisfy Mr. Coleman's tax withholding obligations on shares acquired upon vesting of RSUs. F3 · price: Represents the vesting price which is the average of the high and low share price on August 10, 2018. Read SEC document |
| May 16, 2018 Filed May 17, 2018 17:38 UTC | Endo International plc ENDP · Entity 124463 | Tax withholdingOrdinary Shares | 749 | $6.29 | $4,711.21 |
DisclosureSEC source: 0001209191-18-030810 · doc4.xml · nonDerivative · entry 1 Coleman Blaise · CIK 0001689280 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,396 F1 · date: Thirty-three and a third percent (33 1/3%) of Mr. Coleman's May 16, 2016 grant of restricted stock units (RSUs) vested on May 16, 2018. F2 · shares: These shares represent stock withheld by Endo International plc to satisfy Mr. Coleman's tax withholding obligations on shares acquired upon vesting of RSUs. F3 · price: Represents the vesting price which is the average of the high and low share price on May 16, 2018. Read SEC document |
| April 02, 2018 Filed Apr 4, 2018 18:48 UTC | Endo International plc ENDP · Entity 124463 | Grant2015 Stock Incentive Plan Restricted Stock Units (RSU) | 163,690 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-18-023552 · doc4.xml · nonDerivative · entry 1 Coleman Blaise · CIK 0001689280 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 306,495 F1 · security: Upon each vesting date, each vested restricted stock unit automatically converts into one (1) ordinary share of Endo International plc. One-third (1/3) of these restricted stock units (RSUs) generally vest, thus expire, on each of April 2, 2019, April 2, 2020 and April 2, 2021. F2 · price: These RSUs were granted to Mr. Coleman in consideration of his services as Executive Vice President and Chief Financial Officer of Endo International plc. Read SEC document |
| February 23, 2018 Filed Feb 27, 2018 21:31 UTC | Endo International plc ENDP · Entity 124463 | Tax withholdingOrdinary Shares | 101 | $6.78 | $684.78 |
DisclosureSEC source: 0001209191-18-013925 · doc4.xml · nonDerivative · entry 1 Coleman Blaise · CIK 0001689280 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,465 F1 · date: Twenty-five percent (25%) of Mr. Coleman's February 23, 2016 grant of restricted stock units (RSUs) vested on February 23, 2018. F2 · shares: These shares represent stock withheld by Endo International plc to satisfy Mr. Coleman's tax withholding obligations on shares acquired upon vesting of RSUs. F3 · price: Represents the vesting price which is the average of the high and low share price on February 23, 2018. Read SEC document |
| February 21, 2018 Filed Feb 22, 2018 23:44 UTC | Endo International plc ENDP · Entity 124463 | Tax withholdingOrdinary Shares | 3,595 | $6.72 | $24,158.40 |
DisclosureSEC source: 0001209191-18-012687 · doc4.xml · nonDerivative · entry 1 Coleman Blaise · CIK 0001689280 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,191 F1 · date: Thirty-three and one-third percent (33 1/3%) of Mr. Coleman's February 21, 2017 grant of restricted stock units (RSUs) vested on February 21, 2018. F2 · shares: These shares represent stock withheld by Endo International plc to satisfy Mr. Coleman's tax withholding obligations on shares acquired upon vesting of RSUs. F3 · price: Represents the vesting price which is the average of the high and low share price on February 21, 2018. Read SEC document |
| August 15, 2017 Filed Aug 15, 2017 18:15 UTC | Endo International plc ENDP · Entity 124463 | PurchaseOrdinary Shares | 6,500 | $7.89 | $51,285.00 |
DisclosureSEC source: 0001209191-17-048875 · doc4.xml · nonDerivative · entry 1 Coleman Blaise · CIK 0001689280 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,729 Read SEC document |
| August 10, 2017 Filed Aug 11, 2017 13:03 UTC | Endo International plc ENDP · Entity 124463 | Grant2015 Stock Incentive Plan Stock Options (NQ) · Derivative | 260,416 | $0.00 Strike: $7.55 | $0.00 |
DisclosureSEC source: 0001209191-17-048494 · doc4.xml · derivative · entry 2 Coleman Blaise · CIK 0001689280 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 260,416 Underlying: Ordinary Shares · 260,416 shares Expires 2027-08-10 F3 · security: Represents the right to buy ordinary shares, par value $0.0001 per share, of Endo International plc. F2 · kind: These securities were granted to Mr. Coleman in consideration of his services as Executive Vice President and Chief Financial Officer of Endo International plc. F4 · derivative.exercise_date: These stock options are generally exercisable 33 1/3% per year on each of August 10, 2018, August 10, 2019 and August 10, 2020. Read SEC document |
| August 10, 2017 Filed Aug 11, 2017 13:03 UTC | Endo International plc ENDP · Entity 124463 | GrantStock Incentive Plan Restricted Stock Units (RSU) | 114,583 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-048494 · doc4.xml · nonDerivative · entry 1 Coleman Blaise · CIK 0001689280 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 154,237 F1 · security: Upon each vesting date, each vested restricted stock unit automatically converts into one (1) ordinary share of Endo International plc. These restricted stock units (RSUs) generally vest 33 1/3% per year on each of August 10, 2018, August 10, 2019 and August 10, 2020. Upon vesting, we consider the underlying RSUs to be expired. F2 · kind: These securities were granted to Mr. Coleman in consideration of his services as Executive Vice President and Chief Financial Officer of Endo International plc. Read SEC document |
| May 16, 2017 Filed May 17, 2017 21:42 UTC | Endo International plc ENDP · Entity 124463 | Tax withholdingOrdinary Shares | 830 | $13.33 | $11,063.90 |
DisclosureSEC source: 0001209191-17-033296 · doc4.xml · nonDerivative · entry 1 Coleman Blaise · CIK 0001689280 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,229 F1 · date: Thirty-three and a third percent (33 1/3%) of Mr. Coleman's May 16, 2016 grant of restricted stock units (RSUs) vested on May 16, 2017. F2 · shares: These shares represent stock withheld by Endo International plc to satisfy Mr. Coleman's tax withholding obligations on shares acquired upon vesting of RSUs. F3 · price: Represents the vesting price, which is the average of the high and low share price on May 16, 2017. Read SEC document |
| February 23, 2017 Filed Feb 27, 2017 19:47 UTC | Endo International plc ENDP · Entity 124463 | Tax withholdingOrdinary Shares | 113 | $13.22 | $1,493.86 |
DisclosureSEC source: 0001209191-17-014656 · doc4.xml · nonDerivative · entry 1 Coleman Blaise · CIK 0001689280 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,378 F1 · date: Twenty-five percent (25%) of Mr. Coleman's February 23, 2016 grant of restricted stock units (RSUs) vested on February 23, 2017. F2 · shares: These shares represent stock withheld by Endo International plc to satisfy Mr. Coleman's tax withholding obligations on shares acquired upon vesting of RSUs. F3 · price: $13.22 represents the vesting price, which is the average of the high and low share price on February 23, 2017. Read SEC document |
| February 21, 2017 Filed Feb 23, 2017 21:55 UTC | Endo International plc ENDP · Entity 124463 | Grant2015 Stock Incentive Plan Stock Options (NQ) · Derivative | 74,404 | Not disclosed Strike: $13.19 | Not disclosed |
DisclosureSEC source: 0001209191-17-013845 · doc4.xml · derivative · entry 2 Coleman Blaise · CIK 0001689280 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,404 Underlying: Ordinary Shares · 74,404 shares Expires 2027-02-21 F3 · security: Represents the right to buy ordinary shares, par value $0.0001 per share, of Endo International plc. F2 · price: These securities were granted to Mr. Coleman in consideration of his services as Executive Vice President and Chief Financial Officer of Endo International plc. F4 · derivative.exercise_date: These stock options are generally exercisable 25% per year on each of February 21, 2018, February 21, 2019, February 21, 2020 and February 21, 2021. Read SEC document |
| February 21, 2017 Filed Feb 23, 2017 21:55 UTC | Endo International plc ENDP · Entity 124463 | GrantStock Incentive Plan Restricted Stock Units (RSU) | 33,169 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-17-013845 · doc4.xml · nonDerivative · entry 1 Coleman Blaise · CIK 0001689280 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,711 F1 · security: Upon each vesting date, each vested restricted stock unit automatically converts into one (1) ordinary share of Endo International plc. These restricted stock units (RSUs) generally vest 33 1/3% per year on each of February 21, 2018, February 21, 2019 and February 21, 2020. Upon vesting, we consider the underlying RSUs to be expired. F2 · price: These securities were granted to Mr. Coleman in consideration of his services as Executive Vice President and Chief Financial Officer of Endo International plc. Read SEC document |
| January 28, 2017 Filed Jan 31, 2017 20:49 UTC | Endo International plc ENDP · Entity 124463 | Tax withholdingOrdinary Shares | 1,117 | $11.96 | $13,359.32 |
DisclosureSEC source: 0001209191-17-006348 · doc4.xml · nonDerivative · entry 1 Coleman Blaise · CIK 0001689280 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,115 F1 · date: Fifty percent (50%) of Mr. Coleman's January 28, 2015 grant of restricted stock units (RSUs) vested on January 28, 2017. F2 · shares: These shares represent stock withheld by Endo International plc to satisfy Mr. Coleman's tax withholding obligations on shares acquired upon vesting of RSUs. F3 · price: $11.96 represents the vesting price, which is the average of the high and low share price on January 27, 2017, the last business day prior to the vesting day, which was a Saturday. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.